Finance

Lists
Q2 2027 earnings • released • EPS beat +5.47% • Revenue beat +3.65%
See results
STZ:NYSE
Constellation Brands Inc
$122.64
-0.80%
(-0.99) 1D
$122.60
-0.03% (-0.040)
After hours
Closed: Oct 9, 4:01:47 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STZ...
Open
$123.25
High
$124.18
Low
$121.60
Mkt. cap
20.75B
Avg. vol.
2.64M
Volume
2.38M
Dividend
3.36%
Quarterly dividend
$1.03
Ex-dividend date
Jul 30, 2026
P/E ratio
11.00
52-wk high
$168.60
52-wk low
$110.60
EPS
$11.15
Beta
0.44
Shares outstanding
169.20M
No. of employees
9K
Open
$123.25
High
$124.18
Low
$121.60
Mkt. cap
20.75B
Avg. vol.
2.64M
Volume
2.38M
Dividend
3.36%
Quarterly dividend
$1.03
Ex-dividend date
Jul 30, 2026
P/E ratio
11.00
52-wk high
$168.60
52-wk low
$110.60
EPS
$11.15
Beta
0.44
Shares outstanding
169.20M
No. of employees
9K
News stories
From web sources and news partners
Profile
Constellation Brands, Inc. is an American producer and marketer of beer, wine, and spirits. A Fortune 500 company, Constellation is the largest beer import company in the US, measured by sales, and has the third-largest market share of all major beer suppliers. It also has sizable investments in medical and recreational cannabis through its association with Canopy Growth. Based in Rochester, New York, Constellation has about 40 facilities and approximately 9,000 employees. The company has more than 27 brands in its portfolio. Wine brands include Robert Mondavi, Kim Crawford, Ruffino, and The Prisoner Wine Company. Constellation's beer portfolio includes imported brands such as rights in the United States to Corona, Modelo Especial, Negra Modelo, and Pacífico. Spirits brands include Casa Noble Tequila, High West Whiskey, and Nelson's Green Brier Tennessee Whiskey. Wikipedia
About Constellation Brands Inc
CEONicholas Fink
Employees9.4K
Founded1945
HeadquartersVictor (village), New York, New York, United States
SectorDistillery
Analyst ratings
Based on 20 analysts giving stock ratings to STZ in the past 3 months
Buy
Buy
12
Hold
7
Sell
1
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for STZ in the last 3 months.
Highest
Current $122.64
$209.00 (+70.42%)
Average
$154.47 (+25.95%)
Lowest
$120.00 (-2.15%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Staszak
Argus Research
Hold
Maintained
-
-
10/08/2026
Lauren Lieberman
Barclays
Hold
Maintained
$122.00
-0.5%
10/09/2026
Georgy Vashchenko
Freedom Capital Markets
Buy
Upgraded
$158.00
+28.8%
10/08/2026
Stephen Powers
Deutsche Bank
Hold
Maintained
$127.00
+3.6%
10/08/2026
Seamus Cassidy
TD Cowen
Buy
Maintained
$150.00
+22.3%
10/07/2026
Nik Modi
RBC Capital
Buy
Reiterated
$182.00
+48.4%
10/08/2026
Drew Levine
J.P. Morgan
Hold
Reiterated
$136.00
+10.9%
10/08/2026
Andrew Strelzik
BMO Capital
Buy
Reiterated
$190.00
+54.9%
10/08/2026
Gerald Pascarelli
Needham
Buy
Maintained
$150.00
+22.3%
10/08/2026
Christopher Carey
Wells Fargo
Buy
Reiterated
$140.00
+14.2%
10/08/2026
Peter Grom
UBS
Buy
Maintained
$144.00
+17.4%
10/08/2026
Sorabh Daga
HSBC
Hold
Downgraded
$135.00
+10.1%
10/08/2026
Michael Lavery
Piper Sandler
Hold
Reiterated
$125.00
+1.9%
10/08/2026
Bill Kirk
Roth MKM
Buy
Maintained
$209.00
+70.4%
10/07/2026
Robert Ottenstein
Evercore ISI
Buy
Reiterated
$160.00
+30.5%
10/07/2026
Peter Galbo
Bank of America Securities
Sell
Reiterated
$120.00
-2.2%
10/06/2026
Dara Mohsenian
Morgan Stanley
Hold
Maintained
$145.00
+18.2%
10/08/2026
Bonnie Herzog
Goldman Sachs
Buy
Maintained
$180.00
+46.8%
10/07/2026
Filippo Falorni
Citi
Buy
Maintained
$165.00
+34.5%
09/23/2026
Nadine Sarwat
Bernstein
Buy
Maintained
$197.00
+60.6%
09/15/2026
Robert Moskow
TD Cowen
Buy
Maintained
$174.00
+41.9%
06/30/2026
Kaumil Gajrawala
Jefferies
Hold
Maintained
$157.00
+28%
06/23/2026
Christian Junquera
Bank of America Securities
Sell
Maintained
$154.00
+25.6%
04/15/2026
Last report
Oct 7, 2026
Fiscal period
Q2 2027
$3.74 / $3.55
+5.47%beat
Revenue / Est. (USD)
2.63B / 2.54B
+3.65%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Nov 2025
Feb 2026
May 2026
Aug 2026
Revenue
2.22B
1.92B
2.43B
2.63B
Cost of goods sold
1.04B
964.20M
1.11B
1.24B
Cost of revenue
1.04B
964.20M
1.11B
1.24B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
430.60M
443.60M
448.10M
538.20M
Operating expense
430.60M
443.60M
448.10M
538.20M
Total operating expenses
1.47B
1.41B
1.56B
1.78B
Operating income
753.90M
512.40M
874.10M
854.80M
Other non operating income
-8.10M
-12.10M
-5.10M
-
EBT including unusual items
632.30M
351.20M
760.00M
729.40M
EBT excluding unusual items
686.50M
415.40M
784.00M
779.20M
Income tax expense
110.10M
126.50M
88.10M
147.10M
Effective tax rate
17.41%
36.02%
11.59%
20.17%
Other operating expenses
-
-
-
-
Net income
502.80M
201.80M
653.80M
565.80M
Net profit margin
22.62%
10.51%
26.88%
21.49%
Earnings per share
3.06
1.90
3.43
3.74
Interest and investment income
3.80M
2.50M
2.20M
-
Interest expense
-86.60M
-85.40M
-87.70M
-83.40M
Net interest expenses
-82.80M
-82.90M
-85.50M
-83.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
852.90M
625.50M
971.70M
951.60M
Gain or loss from assets sale
31.90M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps